Eric McIntyre
VP of Finance & IR, Spyre Therapeutics
Professional Overview
Eric McIntyre is an accomplished finance and investor relations executive with extensive experience in the biopharmaceutical industry. As the VP of Finance & IR at Spyre Therapeutics, he is responsible for overseeing the company's financial management, strategic planning, and investor relations activities.
Experience Summary
Current Role
As the VP of Finance & IR at Spyre Therapeutics, Eric is responsible for managing the company's financial operations, including budgeting, forecasting, and financial reporting. He also serves as the primary liaison between the company and the investment community, leading all investor relations efforts and effectively communicating Spyre's strategic vision and financial performance to shareholders and potential investors.
Career Progression
Prior to his current role, Eric served as the Head of Investor Relations at Arcutis Biotherapeutics, where he successfully navigated the company's transition from a private to a publicly traded entity, effectively engaging with the investment community and driving increased visibility and investor interest. Before that, he held various finance leadership positions at Amgen, including Director of Investor Relations, Director of R&D FP&A, and Director of Corporate FP&A, where he demonstrated his ability to drive financial optimization, strategic decision-making, and stakeholder engagement.
Academic Background
Eric holds a Bachelor of Science degree in Finance from the University of Southern California, where he graduated with honors.
Areas of Expertise
- Financial management and strategic planning
- Investor relations and capital markets communications
- Financial modeling and data-driven decision-making
- Biopharmaceutical industry expertise
- Stakeholder engagement and relationship building
Professional Impact
Throughout his career, Eric has played a critical role in driving financial performance and enhancing investor confidence for leading biopharmaceutical companies. His ability to effectively translate complex financial information into meaningful insights has enabled him to secure funding and support for strategic initiatives, ultimately contributing to the growth and success of the organizations he has served.
Conclusion
With his comprehensive finance and investor relations expertise, coupled with his deep understanding of the biopharmaceutical industry, Eric McIntyre is well-positioned to continue driving Spyre Therapeutics' financial and strategic success, while fostering strong relationships with the investment community and elevating the company's profile in the market.
